Our speakers: D

Dávid Dankó
Dávid Dankó
Hans-Peter Dauben
Hans-Peter Dauben
Rosella Di Bidino
Rosella Di Bidino
Joanna Didkowska
Joanna Didkowska
Jaroslav Duba
Jaroslav Duba
Dominik Dziurda
Dominik Dziurda

Our speakersA  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  R  S  T  U  V  W  X  Y  Z

top
Dávid Dankó
Dávid Dankó   |  Hungary

Edition speaker: 20102011 | 2016 | 2018

Managing director, Ideas & Solutions (I&S), research leader, Corvinus University of Budapest Dávid Dankó is managing partner of Ideas & Solutions (I&S), an independent research and consultancy firm which provides health policy and market access advisory services to health insurance organizations and pharma and medical device companies with a focus on emerging and middle-income markets. Dávid has 15 years of experience in health care management & the funding of pharmaceuticals and medical devices. Until 2010 he was member of the executive team for pharmaceutical reform in Hungary as Deputy Director of Reimbursement at the national health insurance fund. Previously he also held a position as research leader at the Corvinus University of Budapest. He speaks regularly at conferences and workshops on pharmaceutical and medical device policies, gives payer communication and negotiation trainings to multinational companies and authorities, and participates at international advisory boards. Focuses: top
Hans-Peter Dauben
Hans-Peter Dauben   |  Germany

Edition speaker: 2020

Dr. Hans-Peter Dauben, born in Moenchengladbach, Germany, is a civil servant at the German Institution for Medical Documentation and Information (DIMDI), Cologne, Germany, an institution within the scope of the Federal Ministry of Health. After finalizing his training as a cardiac surgeon at the University of Duesseldorf, Germany, he moved to DIMDI to establish the German Agency for HTA at DIMDI on behalf of the federal ministry in 2000 and to develop a structure to access HTA information, set priorities in HTA and monitor new technology developments to establish a broad consensus on HTA in Germany. The experiences of information systems developments lead to the nomination of Dr. Dauben as the national representative for information system development at the European medicine agency (EMEA) in London, UK. top

Rosella Di Bidino
Rosella Di Bidino   |  Italy

Edition speaker: 2025

Dr. Rossella Di Bidino leads the Health Technology Assessment (HTA) for Artificial Intelligence Unit at ALTEMS and is a senior HTA expert at Fondazione Policlinico Gemelli IRCCS in Rome. She has broad experience in health technology evaluation at national and EU levels. She serves on Italy’s National Essential Assistance Levels (LEA) Commission, chairs the Hospital-Based HTA Interest Subgroup of HTAi, and is an active leader within ISPOR’s Digital Health SIG and IFMBE’s HTA Division. top
Joanna Didkowska
Joanna Didkowska   |  Poland

Edition speaker: 2020

She has been involved with the Department of Epidemiology of the Oncology Centre in Warsaw since the very beginning of her professional work. Currently, she is the head of the Department of Epidemiology and Cancer Prevention, as well as the head of the National Cancer Registry. Since 2016, she has been the Director of the WHO Collaborating Center for Tobacco Control and a member of the National Council for Oncology at the Minister of Health. She represents the Oncology Centre at the Marie Skłodowska-Curie Institute in Warsaw at the Governmental Population Council. Member of the Public Health Committee of the Polish Academy of Sciences. She participated in population studies concerning risk factors for cancer incidence (tobacco, alcohol, diet, demographic processes), and monitoring the geographical diversification of the incidence and mortality related to malignant neoplasms in Poland. She was the initiator and co-author of studies analysing the survival rate of Polish patients. She co-authored a yearly bulletin on malignant neoplasms in Poland, as well as a study on epidemiological forecasts. She is a member of the Polish TNM Committee of the Union for International Cancer Control (UICC, previously International Union Against Cancer), the Polish Oncological Society, Polish Oncological Union, as well as the Polish Breast Cancer Research Society. Since 2011, she has been section editor in “NOWOTWORY Journal of Oncology” and, since 2016, a member of the editorial team of “Oncology in clinical practice”. She authored over 60 publications. top
Jaroslav Duba
Jaroslav Duba   |  Czech Republic

Edition speaker: 2016 | 2018

Jaroslav founded OAKS Consulting s.r.o. in 2009, after more then 15 years of experience in top management positions in Wyeth, Zentiva and Glaxo. OAKS Consulting has became in short time the leading consulting company providing full scope of services in Market Access in Czech Republic. The team currently consists of 15 specialists with professional background in medicine, pharmacology, mathematical modeling and health-economy. top
Dominik Dziurda
Dominik Dziurda   |  Poland

Edition speaker: 2016 | 2017 | 2018 | 2020 | 2021

Director of the Healthcare Services Department at the Agency for Health Technology Assessment and and Tariff System (AOTMiT). He graduated from the Faculty of Pharmacy at Jagiellonian University Medical College (CMUJ) in Cracow (2002) and the post-graduate programme: MBA for Medical Personnel at the Kozminski University in Warsaw (2010). Doctoral Student at the Warsaw School of Economics (SGH). His work experience includes teaching at universities on subjects related to pharmaceutical law, pharmacoeconomics and organisation of the healthcare system. He has also worked as reimbursement director in national and central structures in the pharmaceutical industry and as an analyst and specialist in projects regarding access to medical care and quality management. President of the technical unit in the Fair and Affordable Pricing project, implemented within the Visegrad Group, a member of the Executive Committee of the POINTer project dedicated to the system of quality indicators. At the AOTMiT he is responsible for i.a. projects related to transformation of the guaranteed services system, with focus on medical rehabilitation, coordinated care and issues concerning clinical practice guidelines. top
Our speakersA  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  R  S  T  U  V  W  X  Y  Z
en_GBEnglish (UK)